Abstract
Single-dose pegfilgrastim is commonly used for the prophylaxis of neutropenia in patients receiving myelotoxic chemotherapy. We report a case of a 69-year-old man who was treated with chemotherapy for small-cell lung cancer and mistakenly self-administered a 36 mg overdose of pegfilgrastim, a sixfold increase over the scheduled dose.
Similar content being viewed by others
References
Curran MP, Goa KL. Pegfilgrastim. Drugs. 2002;62:1207–13.
Martinez C, et al. Efficacy and toxicity of high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors. Bone Marrow Transplant. 1999;24:1273–8.
Pitini V, et al. Spontaneous rupture of spleen during peripheral stem-cell mobilization in a patient with breast cancer. Haematologica. 2000;85:559–60.
Becker PS, et al. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant. 1997;3:45–9.
Donadieu J, Beaupain B, Rety-Jacob F, Nove-Josserand R. Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim. Haematologica. 2009;94:1175–7.
Draper BK, Robbins JB, Stricklin GP. Bullous Sweet’s syndrome in congenital neutropenia: association with pegfilgrastim. J Am Acad Dermatol. 2005;52:901–5.
Schilero GJ, Oropello J, Benjamin E. Impairment in gas exchange after granulocyte colony stimulating factor (GCSF) in a patient with the adult respiratory distress syndrome. Chest. 1995;107:276–8.
Dufour C, et al. Similar favorable outcome of pegfilgrastim overdose in patients with different age and underlying disease. Haematologica. 2010;95:684–5.
Burstein HJ, et al. Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy. J Clin Oncol. 2005;23:8340–7.
Ishiguro H, et al. Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim. Ann Oncol. 2008;19:1019–20.
Wolff AC, Jones RJ, Davidson NE, Jeter SC, Stearns V. Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support. J Clin Oncol. 2006;24:2392–4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaidar–Person, O., Moskovitz, M., Charas, T. et al. Pegfilgrastim overdose: case report and review of the literature. Med Oncol 28 (Suppl 1), 697–698 (2011). https://doi.org/10.1007/s12032-010-9751-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-010-9751-5